Lurbinectedin is a chemotherapy drug used to treat certain types of cancer, including small cell lung cancer and metastatic solid tumors. According to the sources provided, it is unclear if Lurbinectedin has any lasting side effects.

The first source [1] provides information on the patent for Lurbinectedin, but does not mention any information on side effects or lasting effects of the drug.

The second source [2] is from MedlinePlus, a service of the National Library of Medicine, which provides consumer information on prescription drugs. According to the source, the most common side effects of Lurbinectedin include fatigue, nausea, vomiting, decreased appetite, and constipation. Less common side effects include low white blood cell count, anemia, and increased liver enzymes. However, the source does not mention any lasting side effects of the drug.

The third source [3] is from the Mayo Clinic, which provides consumer information on drugs and their side effects. According to the source, the most common side effects of Lurbinectedin include fatigue, nausea, vomiting, decreased appetite, and constipation. Less common side effects include low white blood cell count, anemia, and increased liver enzymes. However, the source does not mention any lasting side effects of the drug.

In conclusion, while Lurbinectedin may cause some side effects, it is unclear if it has any lasting side effects. Patients should consult with their healthcare provider for more information on the potential risks and benefits of Lurbinectedin.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/LURBINECTEDIN
[2] https://medlineplus.gov/druginfo/meds/a620049.html
[3] https://www.mayoclinic.org/drugs-supplements/lurbinectedin-intravenous-route/side-effects/drg-20490804?p=1